Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Sri Rejeki Isman Tbk. (SRIL)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Sri Rejeki Isman Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Sri Rejeki Isman Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 2,99 T). Perbedaan utamanya: Sri Rejeki Isman Tbk. jauh lebih besar — sekitar 28,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SRIL | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 2,99 T |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Sri Rejeki Isman Tbk.
PT Sri Rejeki Isman Tbk (the Company) was establised based on Notarial Deed No. 48 dated May 22, 1978 of Ruth Karliena, S.H., notary in Surakarta.
Selengkapnya di halaman SRIL →
